Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

430 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cholera.
Sack DA, Sack RB, Nair GB, Siddique AK. Sack DA, et al. Among authors: sack rb. Lancet. 2004 Jan 17;363(9404):223-33. doi: 10.1016/s0140-6736(03)15328-7. Lancet. 2004. PMID: 14738797 Review.
Single-dose doxycycline for cholera.
Sack DA, Islam S, Rabbani H, Islam A. Sack DA, et al. Antimicrob Agents Chemother. 1978 Sep;14(3):462-4. doi: 10.1128/aac.14.3.462. Antimicrob Agents Chemother. 1978. PMID: 708024 Free PMC article. Clinical Trial.
Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area.
Clemens JD, Sack DA, Rao MR, Chakraborty J, Khan MR, Kay B, Ahmed F, Banik AK, van Loon FP, Yunus M, et al. Clemens JD, et al. Among authors: sack da. J Infect Dis. 1992 Nov;166(5):1029-34. doi: 10.1093/infdis/166.5.1029. J Infect Dis. 1992. PMID: 1402014 Clinical Trial.
An oral B subunit: whole cell vaccine against cholera.
Holmgren J, Svennerholm AM, Jertborn M, Clemens J, Sack DA, Salenstedt R, Wigzell H. Holmgren J, et al. Among authors: sack da. Vaccine. 1992;10(13):911-4. doi: 10.1016/0264-410x(92)90324-d. Vaccine. 1992. PMID: 1471411 Clinical Trial.
Crossed immunoelectrophoretic analysis of antigenic composition of B-subunit/whole-cell and whole-cell only killed oral cholera vaccines.
Ciznár I, Ahsan CR, Rahman A, Shahabuddin M, Bartková G, Clemens JD, Sack DA. Ciznár I, et al. Among authors: sack da. Vaccine. 1992;10(9):591-6. doi: 10.1016/0264-410x(92)90438-p. Vaccine. 1992. PMID: 1502836
Nonparticipation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines.
Clemens JD, van Loon FF, Rao M, Sack DA, Ahmed F, Chakraborty J, Khan MR, Yunus M, Harris JR, Svennerholm AM, et al. Clemens JD, et al. Among authors: sack da. Am J Epidemiol. 1992 Apr 15;135(8):865-74. doi: 10.1093/oxfordjournals.aje.a116382. Am J Epidemiol. 1992. PMID: 1585899 Clinical Trial.
Biotype as determinant of natural immunising effect of cholera.
Clemens JD, van Loon F, Sack DA, Rao MR, Ahmed F, ChakrabortY J, Kay BA, Khan MR, Yunus MD, Harris JR, et al. Clemens JD, et al. Among authors: sack da. Lancet. 1991 Apr 13;337(8746):883-4. doi: 10.1016/0140-6736(91)90207-6. Lancet. 1991. PMID: 1672971
Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh.
Sack DA, Clemens JD, Huda S, Harris JR, Khan MR, Chakraborty J, Yunus M, Gomes J, Siddique O, Ahmed F, et al. Sack DA, et al. J Infect Dis. 1991 Aug;164(2):407-11. doi: 10.1093/infdis/164.2.407. J Infect Dis. 1991. PMID: 1856488 Clinical Trial.
Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.
Clemens JD, Sack DA, Harris JR, Van Loon F, Chakraborty J, Ahmed F, Rao MR, Khan MR, Yunus M, Huda N, et al. Clemens JD, et al. Among authors: sack da. Lancet. 1990 Feb 3;335(8684):270-3. doi: 10.1016/0140-6736(90)90080-o. Lancet. 1990. PMID: 1967730 Clinical Trial.
Unusual association of a plasmid with nalidixic acid resistance in an epidemic strain of Shigella dysenteriae type 1 from Asia.
Ashraf MM, Ahmed ZU, Sack DA. Ashraf MM, et al. Among authors: sack da. Can J Microbiol. 1991 Jan;37(1):59-63. doi: 10.1139/m91-009. Can J Microbiol. 1991. PMID: 2021898
430 results
Jump to page
Feedback